This webinar will look at the risks and benefits of prescribing medication as part of the treatment for young people with mental health issues The presenter will explore how to manage the preferences and expectations of young people and their families regarding medication use. Consideration will be given to negotiating situations where the young person’s treatment preferences do not align with professional opinions on medication use.
Information in this webinar is current as at December, 2016.
Who is this webinar for?
Clinicians and researchers who work with young people in mental health services, primary care settings and other areas of health and human services.
What will you learn in this webinar?
Appreciate the risks and benefits of medications in youth mental health treatment
Understand the current challenges in using medication as a treatment for mental illness in young people
Understand how to manage expectations of young people and their families for medication use
Appreciate the role of medication as part of integrated, collaborative care in youth mental health services
Professor Andrew Chanen, Deputy Director, Research and Head, Personality Disorder Research at Orygen the National Centre of Excellence in Youth Mental Health
Professor Chanen’s research, clinical and training interests lie in prevention and early intervention for severe mental disorders, principally personality disorders, along with mood and psychotic disorders.
He developed and directs the award-winning Helping Young People Early program, a clinical, research and training program run by Orygen that is focused on understanding, preventing and treating severe personality disorder in young people.
Andrew has been the President of the International Society for the Study of Personality Disorders since 2011 and an Executive Board Member since 2003. He serves on the editorial boards of Early Intervention in Psychiatry, Psychopathology, Personality and Mental Health and is a reviewer for local and international scientific journals.
Andrew’s research includes the published first randomised controlled trial of early intervention for borderline personality disorder in young people.